- Home
- FSI vs ONCY Comparison
FSI vs ONCY Comparison
Compare FSI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- ONCY
- Stock Information
- Founded
- FSI 1991
- ONCY 1998
- Country
- FSI Canada
- ONCY Canada
- Employees
- FSI N/A
- ONCY N/A
- Industry
- FSI Recreational Games/Products/Toys
- ONCY Pharmaceuticals and Biotechnology
- Sector
- FSI Consumer Discretionary
- ONCY Health Care
- Exchange
- FSI Nasdaq
- ONCY Nasdaq
- Market Cap
- FSI 55.6M
- ONCY 49.1M
- IPO Year
- FSI 1999
- ONCY 1999
- Fundamental
- Price
- FSI $4.32
- ONCY $0.36
- Analyst Decision
- FSI
- ONCY Strong Buy
- Analyst Count
- FSI 0
- ONCY 4
- Target Price
- FSI N/A
- ONCY $4.33
- AVG Volume (30 Days)
- FSI 27.7K
- ONCY 940.6K
- Earning Date
- FSI 05-15-2025
- ONCY 07-31-2025
- Dividend Yield
- FSI 2.27%
- ONCY N/A
- EPS Growth
- FSI N/A
- ONCY N/A
- EPS
- FSI 0.18
- ONCY N/A
- Revenue
- FSI $36,483,680.00
- ONCY N/A
- Revenue This Year
- FSI $21.91
- ONCY N/A
- Revenue Next Year
- FSI $42.35
- ONCY N/A
- P/E Ratio
- FSI $24.18
- ONCY N/A
- Revenue Growth
- FSI N/A
- ONCY N/A
- 52 Week Low
- FSI $1.65
- ONCY $0.33
- 52 Week High
- FSI $7.24
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- FSI 50.69
- ONCY 33.81
- Support Level
- FSI $4.22
- ONCY $0.37
- Resistance Level
- FSI $4.55
- ONCY $0.37
- Average True Range (ATR)
- FSI 0.23
- ONCY 0.04
- MACD
- FSI -0.00
- ONCY -0.00
- Stochastic Oscillator
- FSI 42.59
- ONCY 19.63
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.